Breast Cancer Update cover art

Breast Cancer Update

Breast Cancer Update

By: Dr. Neil Love
Listen for free

Season's Savings | £0.99/mo for 3 months

£5.99/mo after 3 months - terms apply. Cancel monthly
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.Copyright 2025 Research To Practice. All Rights Reserved Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney

    Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney
    Oct 10 2026

    Featuring perspectives from Dr Sara M Tolaney, including the following topics:

    • Management of adverse events associated with TROP2-targeting antibody-drug conjugates (0:00)
    • Managing brain metastases in triple-negative breast cancer (6:30)
    • EGFR x HER3-directed bispecific antibodies for metastatic triple-negative breast cancer (mTNBC) (9:11)
    • PD-1/PD-L1 x VEGF-directed bispecific antibodies for mTNBC (12:31)

    CME information and select publications
    Show More Show Less
    19 mins
  • Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 3 with Dr Sara M Tolaney

    Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 3 with Dr Sara M Tolaney
    Oct 9 2026

    Featuring perspectives from Dr Sara M Tolaney, including the following topics:

    • Mechanistic effects and potential resistance mechanisms of antibody-drug conjugates (0:00)
    • First-line treatment of metastatic triple-negative breast cancer (mTNBC) in patients eligible for immunotherapy (7:13)
    • First-line treatment of mTNBC in patients ineligible for immunotherapy (13:02)
    • Antibody-drug conjugates for previously treated HER2-low metastatic breast cancer (19:15)

    CME information and select publications
    Show More Show Less
    25 mins
  • Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 2 with Dr David W Cescon

    Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 2 with Dr David W Cescon
    Sep 22 2026

    Featuring perspectives from Dr David W Cescon, including the following topics:

    • Clinical treatment of BRCA-mutated metastatic triple-negative breast cancer (0:00)
    • CNS activity of TROP2-directed antibody-drug conjugates (5:36)
    • Autoimmune considerations with immunotherapy (10:09)
    • Treatment of oligoprogressive advanced breast cancer (17:31)

    CME information and select publications
    Show More Show Less
    24 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet